MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
13:51
The interim Minister of Defense, Radu Miruţă, about the future government: "We have stated what the thresholds are for us to sit at the table, we will no longer vote for a government with PSD. PNL, USR, and UDMR no longer have a place in the same chamber with PSD."
13:50
The BNR launches a silver coin dedicated to Nicolae Tonitza, on the 140th anniversary of his birth. The coin is rectangular in shape and is worth 10 lei.
13:48
Major breakdown on the Berceni Pipeline: Sector 4 remains without hot water
13:43
Spontaneous protest in Arad, dozens of victims demand the recovery of their money or the delivery of the paid cars
13:41
ANALYSIS The romantic rumor is not the problem. Rather, it is Natalie Harp's access to Trump.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
